Cargando…
Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma
Acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first identified in Wuhan, China; and spread all over the world. Reverse-transcription polymerase chain reaction (RT-PCR) test for SARS-CoV-2 usually returns to negative in 20 days post-infection, but prolonged positivity has been reported up to...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333597/ https://www.ncbi.nlm.nih.gov/pubmed/32694044 http://dx.doi.org/10.1016/j.transci.2020.102871 |
_version_ | 1783553786973782016 |
---|---|
author | Karataş, Ayşe İnkaya, Ahmet Çağkan Demiroğlu, Haluk Aksu, Salih Haziyev, Tahmaz Çınar, Olgu Erkin Alp, Alpaslan Uzun, Ömrüm Sayınalp, Nilgün Göker, Hakan |
author_facet | Karataş, Ayşe İnkaya, Ahmet Çağkan Demiroğlu, Haluk Aksu, Salih Haziyev, Tahmaz Çınar, Olgu Erkin Alp, Alpaslan Uzun, Ömrüm Sayınalp, Nilgün Göker, Hakan |
author_sort | Karataş, Ayşe |
collection | PubMed |
description | Acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first identified in Wuhan, China; and spread all over the world. Reverse-transcription polymerase chain reaction (RT-PCR) test for SARS-CoV-2 usually returns to negative in 20 days post-infection, but prolonged positivity has been reported up to 63 days. A case whose viral shedding lasted 60 days is reported from China. Herein we report a patient with a history of autologous stem cell transplantation (ASCT) for lymphoma whose RT-PCR test remained positive for SARS-CoV-2 for 74 days. The prolonged RT-PCR positivity, despite convalescent plasma infusion, may suggest that the given antibodies may be ineffective in terms of viral clearance. In patients with hematological malignancies or immunosuppression, such as ASCT, may lead to prolonged viral shedding, and strict isolation is warranted for long-term SARS-CoV-2 infection control. |
format | Online Article Text |
id | pubmed-7333597 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73335972020-07-06 Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma Karataş, Ayşe İnkaya, Ahmet Çağkan Demiroğlu, Haluk Aksu, Salih Haziyev, Tahmaz Çınar, Olgu Erkin Alp, Alpaslan Uzun, Ömrüm Sayınalp, Nilgün Göker, Hakan Transfus Apher Sci Case Report Acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first identified in Wuhan, China; and spread all over the world. Reverse-transcription polymerase chain reaction (RT-PCR) test for SARS-CoV-2 usually returns to negative in 20 days post-infection, but prolonged positivity has been reported up to 63 days. A case whose viral shedding lasted 60 days is reported from China. Herein we report a patient with a history of autologous stem cell transplantation (ASCT) for lymphoma whose RT-PCR test remained positive for SARS-CoV-2 for 74 days. The prolonged RT-PCR positivity, despite convalescent plasma infusion, may suggest that the given antibodies may be ineffective in terms of viral clearance. In patients with hematological malignancies or immunosuppression, such as ASCT, may lead to prolonged viral shedding, and strict isolation is warranted for long-term SARS-CoV-2 infection control. Elsevier Ltd. 2020-10 2020-07-03 /pmc/articles/PMC7333597/ /pubmed/32694044 http://dx.doi.org/10.1016/j.transci.2020.102871 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Case Report Karataş, Ayşe İnkaya, Ahmet Çağkan Demiroğlu, Haluk Aksu, Salih Haziyev, Tahmaz Çınar, Olgu Erkin Alp, Alpaslan Uzun, Ömrüm Sayınalp, Nilgün Göker, Hakan Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma |
title | Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma |
title_full | Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma |
title_fullStr | Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma |
title_full_unstemmed | Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma |
title_short | Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma |
title_sort | prolonged viral shedding in a lymphoma patient with covid-19 infection receiving convalescent plasma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333597/ https://www.ncbi.nlm.nih.gov/pubmed/32694044 http://dx.doi.org/10.1016/j.transci.2020.102871 |
work_keys_str_mv | AT karatasayse prolongedviralsheddinginalymphomapatientwithcovid19infectionreceivingconvalescentplasma AT inkayaahmetcagkan prolongedviralsheddinginalymphomapatientwithcovid19infectionreceivingconvalescentplasma AT demirogluhaluk prolongedviralsheddinginalymphomapatientwithcovid19infectionreceivingconvalescentplasma AT aksusalih prolongedviralsheddinginalymphomapatientwithcovid19infectionreceivingconvalescentplasma AT haziyevtahmaz prolongedviralsheddinginalymphomapatientwithcovid19infectionreceivingconvalescentplasma AT cınarolguerkin prolongedviralsheddinginalymphomapatientwithcovid19infectionreceivingconvalescentplasma AT alpalpaslan prolongedviralsheddinginalymphomapatientwithcovid19infectionreceivingconvalescentplasma AT uzunomrum prolongedviralsheddinginalymphomapatientwithcovid19infectionreceivingconvalescentplasma AT sayınalpnilgun prolongedviralsheddinginalymphomapatientwithcovid19infectionreceivingconvalescentplasma AT gokerhakan prolongedviralsheddinginalymphomapatientwithcovid19infectionreceivingconvalescentplasma |